Market revenue in 2023 | USD 977.1 million |
Market revenue in 2030 | USD 1,620.5 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Drug Eluting Stents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.08% in 2023. Horizon Databook has segmented the South Africa drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
Factors such as rising healthcare spending, growing prevalence of cancer, and increasing number of minimally invasive surgeries are expected to drive market growth in South Africa during the forecast period. Furthermore, the government in the country has been adopting measures to improve the state of healthcare facilities.
The government allocates 11% of the resources to the healthcare sector from the total government expenditure. There are more than 200 private hospitals and over 400 public hospitals in the country. About 40% of the total healthcare expenditure is carried out by the government. Due to this, the private sector is under pressure to provide appropriate services to most citizens.
This is expected to drive the market in the near future. The rising prevalence of chronic diseases like cancer & diabetes in the country may offer lucrative opportunities for the market. For instance, according to the International Diabetes Federation, diabetes prevalence reached 11.3% and accounted for 96,000 deaths in South Africa in 2021.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into South Africa drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account